Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CALCRL contributors: mct - updated : 20-12-2018
HGNC name calcitonin receptor-like
HGNC id 16709
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N terminal-CALCRL is structured and further a significant part of the binding affinity comes from binding to the N terminal-domain
  • C-tail is crucial for ADM-evoked cAMP production and internalization of the CALCRL/RAMP2
  • conjugated GlycoP
    HOMOLOGY
    interspecies homolog to murine Calcrl
    Homologene
    FAMILY G protein-coupled receptor family 2
    CATEGORY signaling hormone , receptor membrane G
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    intracellular,cytoplasm,organelle,endosome
    intracellular,cytoplasm,organelle,lysosome
    basic FUNCTION
  • can engage signaling partners, such as G proteins and beta-arrestin, following CGRP stimulation, only in the presence of RAMP1
  • requires coexpression of different receptor activity modifying proteins (RAMP) to become a functional calcitonin gene-related peptide (CGRP) receptor or an adrenomedullin (AM) receptor
  • acts as a receptor for the calcitonin gene-related peptide (CALCA) but in order to recognize CALCA, it must form a complex with an accessory protein, receptor activity modifying protein 1 (RAMP1)
  • CALCRL is an important factor in aging and associated disorders
  • ADM receptor components CALCRL and RAMP2 gene expression increased with increasing gestational age
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling hormonal
    a component
  • functional CGRP receptors result from the association of a homo-oligomer of the calcitonin receptor-like receptor with a monomer of the accessory protein receptor activity-modifying protein-1 (RAMP1)
  • forms a heterodimer with receptor activity-modifying protein 2 (RAMP2)
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • RCP9
  • interacting with RAMP1 (requires the assembly of the seven-transmembrane domain calcitonin receptor-like receptor with the single-transmembrane domain receptor activity-modifying prtein-1 to reach the cell surface and be active)
  • TNFSF11 induces the formation of receptors for calcitonin (CALCRL)and CALCA in the bone marrow macrophages (BMM)3)
  • with RAMP2 serves as the adrenomedullin (AM) receptor to control neovascularization
  • CALCA exerts its diverse effects on vasodilation, nociception, secretion, and motor function through a heterodimeric receptor comprising of CALCRL and receptor activity-modifying protein 1 (RAMP1)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in clear cell renal cell carcinoma, in advanced stages, correlated with high tumor grade and conferred shorter overall survival
    tumoral     --over  
    in acute myeloid leukemia with increased mortality
    Susceptibility
  • to essential hypertension
  • to gestational diabetes (GDM)
  • Variant & Polymorphism SNP
  • 8SNP
  • two CALCRL variants were associated with gestational diabetes (GDM) risk
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerurinary 
    target for future functional studies and drug development in clear cell renal cell carcinoma
    ANIMAL & CELL MODELS